Display options
Cite
Chen P, Russo BC, Duncan-Lowey JK, et al. Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB. mBio. 2021;e0302121doi: 10.1128/mBio.03021-21.
Chen, P., Russo, B. C., Duncan-Lowey, J. K., Bitar, N., Egger, K. T., & Goldberg, M. B. (2021). Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB. mBio, e0302121. https://doi.org/10.1128/mBio.03021-21
Chen, Poyin, et al. "Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB." mBio vol. (2021): e0302121. doi: https://doi.org/10.1128/mBio.03021-21
Chen P, Russo BC, Duncan-Lowey JK, Bitar N, Egger KT, Goldberg MB. Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB. mBio. 2021 Nov 23;e0302121. doi: 10.1128/mBio.03021-21. Epub 2021 Nov 23. PMID: 34809452; PMCID: PMC8609354.
Copy Download .nbib Format: NLM
Share it on

mBio. 2021 Nov 23;e0302121. doi: 10.1128/mBio.03021-21. Epub 2021 Nov 23.

Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB.

mBio

Poyin Chen, Brian C Russo, Jeffrey K Duncan-Lowey, Natasha Bitar, Keith T Egger, Marcia B Goldberg

Affiliations

  1. Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospitalgrid.32224.35, Boston, Massachusetts, USA.
  2. Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.
  3. Broad Institute, Cambridge, Massachusetts, USA.

PMID: 34809452 PMCID: PMC8609354 DOI: 10.1128/mBio.03021-21

[No abstract available.]

Keywords: IpaB; Shigella flexneri; topology; translocon; type 3 secretion

References

  1. PLoS Pathog. 2019 Nov 14;15(11):e1007928 - PubMed
  2. Infect Immun. 2010 Dec;78(12):4999-5010 - PubMed
  3. PLoS Pathog. 2021 Sep 9;17(9):e1009932 - PubMed
  4. Nat Commun. 2015 Dec 11;6:10114 - PubMed
  5. Cell Death Dis. 2012 Sep 06;3:e384 - PubMed
  6. Mol Microbiol. 2007 Mar;63(6):1719-30 - PubMed
  7. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4577-81 - PubMed
  8. Protein Sci. 2013 May;22(5):614-27 - PubMed
  9. Lancet Infect Dis. 2017 Sep;17(9):909-948 - PubMed
  10. PLoS Genet. 2017 Jan 13;13(1):e1006556 - PubMed
  11. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5 - PubMed
  12. J Bacteriol. 1964 Nov;88(5):1503-18 - PubMed
  13. PLoS Pathog. 2016 Mar 29;12(3):e1005530 - PubMed
  14. Cell Microbiol. 2001 Oct;3(10):669-79 - PubMed
  15. Biochim Biophys Acta. 2008 Apr;1783(4):629-40 - PubMed
  16. Mol Microbiol. 2003 Jul;49(2):425-39 - PubMed
  17. J Cell Biol. 1999 Nov 1;147(3):683-93 - PubMed
  18. Eur J Biochem. 2000 Sep;267(18):5769-76 - PubMed
  19. Nat Microbiol. 2016 Mar 07;1:16025 - PubMed
  20. Mol Microbiol. 2008 Jun;68(5):1085-95 - PubMed
  21. mBio. 2019 May 28;10(3): - PubMed
  22. Microbiology (Reading). 2018 Apr;164(4):540-550 - PubMed
  23. Infect Immun. 1984 Oct;46(1):251-9 - PubMed
  24. Proteins. 2014 Nov;82(11):3013-22 - PubMed
  25. Elife. 2018 Oct 03;7: - PubMed
  26. BMC Genomics. 2017 Apr 4;18(1):279 - PubMed
  27. Infect Immun. 1997 Oct;65(10):4005-10 - PubMed
  28. Methods. 2007 Apr;41(4):439-50 - PubMed
  29. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1254-8 - PubMed
  30. Mol Microbiol. 2000 Sep;37(5):1133-45 - PubMed

Publication Types

Grant support